Budget 2018-19

  An independent Covid-19 vaccine safety monitoring board considered that the woman’s death was due to myocarditis, which is known to be a rare side effect of the Pfizer Covid-19 vaccine New Zealand on Monday reported what authorities said was the country’s first recorded death linked to the Pfizer Covid-19 vaccine. The information was released by the health ministry following a review by an independent Covid-19 vaccine safety monitoring board of the death of a woman after receiving the vaccine. The ministry’s statement did not give the woman’s age. The board considered that the woman’s death was due to myocarditis, which is known to be a rare side effect of the  Pfizer Covid-19 vaccine , the statement said. Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms. “This is the first case in  New Zealand  where a death in the days following vaccination has been linked to the Pfizer ...

  We now have agreements in place with four providers and we have secured more than enough vaccine doses to cover our entire population plus the Pacific, Jacinda Arden said The New Zealand government will purchase COVID-19 vaccines from pharmaceutical companies AstraZeneca and Novavax, meaning every New Zealander will be able to be vaccinated, Prime Minister Jacinda Ardern said on Thursday. The new agreements secure access to 7.6 million doses from AstraZeneca — enough for 3.8 million people, and 10.72 million doses from Novavax — enough for 5.36 million people. Both vaccines require two doses to be administered, according to a government statement. The four pre-purchase agreements secured to date are 750,000 courses from  Pfizer/BioNTech ; 5 million courses from Janssen; 3.8 million courses from the University of Oxford/AstraZeneca; and 5.36 million courses from Novavax, said the statement. There are multiple types of vaccine technology that have been used to develop COVID-19...